{"database": "lobbying", "table": "lobbying_activities", "rows": [[2431792, "4f1da57a-bb66-4faa-9828-597be39adf0a", "Q1", "MASSACHUSETTS BIOTECHNOLOGY COUNCIL", 400271247, "MASSACHUSETTS BIOTECHNOLOGY COUNCIL", 2020, "first_quarter", "MED", "Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Patent & Trademark Office (PTO),SENATE", null, 25000, 0, 0, "2020-04-17T13:12:15.377000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2431792"], "units": {}, "query_ms": 0.4925929824821651, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}